Lulipex Gel contains Luliconazole 1% w/w, a topical antifungal agent belonging to the imidazole class, indicated for the treatment of superficial fungal infections of the skin. Luliconazole exhibits broad-spectrum antifungal activity against dermatophytes, yeasts, and molds by inhibiting the synthesis of ergosterol, an essential component of the fungal cell membrane, thereby disrupting membrane integrity and leading to fungal cell death. This formulation is primarily used in the management of conditions such as tinea corporis, tinea cruris, and tinea pedis. Lulipex Gel is applied once daily to the affected area, ensuring adequate coverage and absorption, typically for a duration of 2 to 4 weeks depending on the severity and type of infection. The gel base facilitates rapid penetration and provides a non-greasy, cosmetically acceptable vehicle that enhances patient compliance. Adverse effects are generally mild and infrequent, including localized burning, itching, or erythema at the application site. Lulipex Gel should be used with caution in patients with known hypersensitivity to luliconazole or any components of the formulation. It is contraindicated in mucosal infections and should not be applied to open wounds. As with all topical antifungals, treatment should be continued for the prescribed duration to prevent recurrence and resistance development.